Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/05/2024 BST 		5-day change 1st Jan Change
4.77 USD +0.21% Intraday chart for Vanda Pharmaceuticals Inc. +3.02% +13.03%
04-25 Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer RE
04-22 Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court MT

Chart calendar Vanda Pharmaceuticals Inc.

367eb1d3511ad8a8a16d63733f23813.fkCSN7bLFx0g8ZPpBmHbCMZ-5zVnPKri6R54QTNjAjo.TSKkb8Oufm9lkt-Bbxu5b4MK0EwrT8Cn2G0-FgIab3w3Ct5Gm7hmUUSHwg~2ffe898de3074d8bfe2a5ad277151dbd

Upcoming events on Vanda Pharmaceuticals Inc.

30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
04/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Vanda Pharmaceuticals Inc.

30/04/2024 Q1 2024 Earnings Release (Projected)
07/02/2024 21:30 Q4 2023 Earnings Call
07/02/2024 21:02 Q4 2023 Earnings Release
09/01/2024 17:45 JPMorgan Healthcare Conference
16/11/2023 14:00 Jefferies London Healthcare Conference
14/11/2023 21:10 Stifel Healthcare Conference
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:01 Q3 2023 Earnings Release
11/10/2023 18:25 Jefferies Inaugural Biotech CNS/Neuro Summit
13/09/2023 21:00 H.C. Wainwright Global Investment Conference
27/07/2023 21:30 Q2 2023 Earnings Call
26/07/2023 Q2 2023 Earnings Release After hours
09/06/2023 17:15 Jefferies Global Healthcare Conference
08/06/2023 14:00 Annual General Meeting
03/05/2023 21:30 Q1 2023 Earnings Call
03/05/2023 21:01 Q1 2023 Earnings Release
08/02/2023 21:30 FY 2022 Earnings Call
08/02/2023 21:01 FY 2022 Earnings Release
12/01/2023 20:00 JP Morgan Healthcare Conference
17/11/2022 12:20 Jefferies London Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		227
226
0.61%		248
245
1.5%		269
271
-0.75%		254
258
-1.21%		193
184
4.47%
195

EBITDA
Million USD		Released
Forecast
Spread 		39,2
27,8
40.86%		0,00
0,00
- 		45,0
45,5
-1.04%		0,00
0,00
- 		0,00
0,00
-
-20,2

EBIT
Million USD		Released
Forecast
Spread 		22,8
32,3
-29.38%		27,2
24,2
12.56%		42,2
40,4
4.45%		6,33
5,50
15.07%		-14,0
-18,4
24.17%
-21,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		29,0
33,9
-14.37%		31,7
25,9
22.22%		42,4
40,3
5.12%		11,3
6,20
82.26%		6,34
2,60
143.81%
-1,90

Net income
Million USD		Released
Forecast
Spread 		116
121
-4.74%		23,3
24,1
-3.17%		33,2
31,1
6.58%		6,28
2,70
132.41%		2,51
-0,50
601.8%
-3,60

EPS
USD		Released
Forecast
Spread 		2,11
2,17
-2.76%		0,42
0,46
-7.74%		0,58
0,54
8.41%		0,11
0,04
175%		0,04
-0,01
500%
-0,06

Announcement Date25/02/2010/02/2123/02/2208/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		68,0
70,0
-2.88%		60,2
58,0
3.78%		64,4
67,0
-3.9%		65,3
71,0
-8%		64,5
67,6
-4.61%		46,1
49,0
-6.01%		38,8
44,5
-12.78%		45,3
37,0
22.35%
EBITDA
Million USD		Released
Forecast
Spread 		9,34
9,28
0.72%




















EBIT
Million USD		Released
Forecast
Spread 		8,64
6,65
29.8%		-7,67
-0,60
-1178.17%		3,46
9,70
-64.32%		3,91
6,60
-40.79%		6,63
5,80
14.29%		-2,87
-9,40
69.5%		-6,00
-2,60
-130.58%		-7,09
-11,5
38.31%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		8,61
6,20
38.87%		-7,56
-0,60
-1160.67%		3,79
9,70
-60.93%		5,46
6,90
-20.86%		9,61
6,10
57.59%		2,59
-9,40
127.57%		-0,12
-2,60
95.38%		-1,66
-5,40
69.24%
Net income
Million USD		Released
Forecast
Spread 		7,08
4,87
45.42%		-6,43
-0,50
-1186%		2,57
7,70
-66.57%		3,27
5,40
-39.44%		6,86
4,80
42.94%		1,52
-7,50
120.27%		0,14
-2,60
105.27%		-2,40
-5,40
55.56%
EPS
USD		Released
Forecast
Spread 		0,12
0,09
41.18%		-0,11
-0,01
-1000%		0,05
0,12
-58.33%		0,06
0,09
-33.33%		0,12
0,08
50%		0,03
-0,13
123.08%		0,00
-0,04
- 		-0,04
-0,09
55.56%
Announcement Date23/02/2205/05/2203/08/2202/11/2208/02/2327/07/2308/11/2307/02/24

Upcoming sector events for Vanda Pharmaceuticals Inc.

Today 11:00 AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
Today 11:30 SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 11:30 REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 12:00 AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 16:00 GENMAB A/S: Q1 2024 Earnings Release
Today 21:01 ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
05/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
05/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
05/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
05/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Vanda Pharmaceuticals Inc.

Today ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
Today DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
Today GERON CORPORATION: Q1 2024 Earnings Release
Today KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
Today KEROS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ALECTOR, INC.: Q1 2024 Earnings Release (Projected)
Today ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
Today TRAVERE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ARDELYX, INC.: Q1 2024 Earnings Release
Today ZYMEWORKS INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. Calendar Vanda Pharmaceuticals Inc.